Risultati di ricerca - Portale di modelli di dati medici (MDM-Portal)

Z6051 Registration Worksheet (RW) NCT00726622

- 20/09/21 - 1 modulo, 9 itemgroups, 67 elementi, 1 linguaggio

Itemgroups: Header module, Pre-Neoadjuvant Therapy Examination Data, Neoadjuvant Therapy Date, Footer Module, Patient Information, Eligibility Criteria, Randomization, Colorectal Surgical Procedure, Consent

Z6051 Registration Worksheet (RW) NCT00726622 Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Stage IIA, Stage IIIA, or Stage IIIB Rectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=42C2D65A-ED39-4B6E-E044-0003BA3F9857

ACOSOG-Z1072 OPEN Registration Worksheet NCT00723294

- 20/09/21 - 1 modulo, 3 itemgroups, 27 elementi, 1 linguaggio

Itemgroups: Patient demographics, General Information, Eligibility Checklist

ACOSOG-Z1072 OPEN Registration Worksheet NCT00723294 Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7FF941F7-5D5F-47CE-E040-BB89AD432465

Colorectal Cancer NCT01189227 Registration - NSABP C-11 OPEN Worksheet for Form Entry - 3105627v1.0 - NSABP C-11 OPEN Worksheet for Form Entry

- 20/09/21 - 1 modulo, 12 itemgroups, 106 elementi, 1 linguaggio

Itemgroups: Header Module, Race, Demographics, Patient Consent, Page Headers, Section 1 - Surgery and Pathology, Section 2 - Imaging Studies, Section 2 -Imaging Studies (continued), Section 3 - Baseline Values (I), Section 3 - Baseline Values (II), Section 3 - Baseline Values (III), Section 4 - Patient History, Current and Recent Conditions

NSABP C-11 OPEN Worksheet for Form Entry Combination Chemotherapy Before or After Surgery in Treating Patients With Colorectal Cancer With Liver Metastases That Could Be Removed By Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8836C32C-ED52-3A5B-E040-BB89AD436D98

Breast Cancer NCT01275677 Registration - NSABP Protocol B-47 Worksheet for Form Entry - 3155372v1.0 - NSABP Protocol B-47 Worksheet for Form Entry

- 20/09/21 - 1 modulo, 11 itemgroups, 139 elementi, 1 linguaggio

Itemgroups: Header, Patient Consent, SECTION 1 - HER2 Status, SECTION 2 - Surgery and Pathology, Section 3 - Baseline Values (I), Section 3 - Baseline Values (II), Section 3 - Baseline Values (III), SECTION 3 - Baseline Values (IV), SECTION 4 - Patient History, SECTION 5 - Menopausal Status, Footer Module

NSABP Protocol B-47 Worksheet for Form Entry A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women With Node- Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=942D0C00-2D04-589C-E040-BB89AD433FFB

Colon cancer (NSABP C-08 NCT00096278) - REGISTRATION FORM Colon cancer (NCT00096278)

- 20/09/21 - 1 modulo, 3 itemgroups, 64 elementi, 1 linguaggio

Itemgroups: Header, Patient characteristics, Eligibility Checklist

NSABP PROTOCOL C-08: REGISTRATION FORM Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer NCT00096278 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D7F6865F-B506-428D-E034-0003BA12F5E7

Pre-Randomization Colon Cancer Stage III N0147 NCT00079274

- 20/09/21 - 1 modulo, 12 itemgroups, 70 elementi, 1 linguaggio

Itemgroups: Header module, Visit, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics, KRAS Results Contact, KRAS Results Contact (alternate), Eligibility Check, Contraindications, Pre-Randomization Check, The following will also be recorded:, The following will also be recorded:, Protocol Design

Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=70E10B08-8A7D-A35C-E040-BB89AD432A74

CALGB COOPERATIVE GROUP ADJUVANT BREAST CANCER RANDOMIZATION NCT00016276

- 20/09/21 - 1 modulo, 4 itemgroups, 38 elementi, 1 linguaggio

Itemgroups: CALGB Information, PROTOCOL ADMINISTRATION, PATIENT DEMOGRAPHICS / PRE u TREATMENT CHARACTERISTICS, STRATIFICATION FACTORS

CALGB COOPERATIVE GROUP ADJUVANT BREAST CANCER RANDOMIZATION NCT00016276 Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9E35395C-8542-227A-E034-080020C9C0E0

Registration Worksheet Breast Cancer Z1041 NCT00513292

- 20/09/21 - 1 modulo, 13 itemgroups, 81 elementi, 1 linguaggio

Itemgroups: Header Module, Patient Information, Consent, Inclusion Criteria, Exclusion Criteria, Eligibility Assessment, Method of Evaluation, Pregnancy Test, Primary Tumor Biopsy, Clinical Stage, Laboratory Values, History, Footer

Z1041: Registration Worksheet NCT00513292 Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=211E7BC7-C479-7160-E044-0003BA3F9857

CALGB Randomization (CALGB 49903) NCT00053339

- 20/09/21 - 1 modulo, 6 itemgroups, 39 elementi, 1 linguaggio

Itemgroups: Header, PROTOCOL ADMINISTRATION, PATIENT DEMOGRAPHICS / PRE-TREATMENT CHARACTERISTICS, CERTIFICATION OF ELIGIBILITY, Registration data, CCRR MODULE

CALGB Randomization (CALGB 49903) NCT00053339 Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A73D2B92-2BAF-4794-E034-0003BA0B1A09

NSABP PROTOCOL R-04: REGISTRATION FORM NCT00058474

- 20/09/21 - 1 modulo, 9 itemgroups, 74 elementi, 1 linguaggio

Itemgroups: Header, Person Completing Form, Last Name, Required Studies, Staging of Primary Tumor, Quality of Life, Hematologies, Chemistries, Tumor Extension, Biopsy specimen

NSABP PROTOCOL R-04: REGISTRATION FORM NCT00058474 Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B7825AE7-F18A-259D-E034-0003BA12F5E7